Bluegrass Vascular Technologies, Inc.

14 articles about Bluegrass Vascular Technologies, Inc.

• Bluegrass Vascular Announces Decision by Medicare to Assign a New Technology Ambulatory Payment Classification (APC) for the Surfacer® System Procedure

  9/20/2021

  Bluegrass Vascular Technologies announced that the Centers for Medicare & Medicaid Services has finalized a new Healthcare Common Procedure Coding System code and New Technology Ambulatory Payment Classification assignment for use of the Surfacer® Inside-Out® Access Catheter System procedure.

• Bluegrass Vascular Technologies Welcomes National Kidney Foundation's Revamp of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Vascular Access

  4/14/2020

  Updated 2019 guidelines emphasize vessel preservation, aligns with the Surfacer® System's "Don't Go Left™" approach

• American Journal of Kidney Diseases Publishes Positive Clinical Results in First Independent, Multicenter Study of the Surfacer® Inside-Out® Access Catheter System

  12/19/2019

  The publication highlights the first-ever independent, multicenter study investigating the applicability of the Surfacer System, a novel approach to achieving right-sided, upper body central venous access in patients with obstructions or other conditions that preclude central venous access by conventional methods.

• Journal Of Vascular Access Publishes Positive Clinical Results For Bluegrass Vascular's Surfacer® System

  9/24/2019

  Additional clinical evidence to be highlighted at upcoming Controversies in Dialysis Access (CiDA) and American Society of Nephrology (ASN) meetings

• Bluegrass Vascular Announces Enrollment Completion And Positive Results In U.S. Pivotal IDE Trial

  6/4/2019

  Bluegrass Vascular Technologies announced it has successfully completed enrollment of the SAVE-US pivotal trial evaluating the safety and efficacy of the Surfacer® Inside-Out® Access Catheter System in thirty patients across 7 U.S. centers.

• Surfacer® Inside-Out® Access Catheter System to be Featured at 2019 Charing Cross (CX) International Annual Symposium

  4/15/2019

  Positive results of single-center, prospective study to be presented along with several educational sessions

• Bluegrass Vascular Announces Positive Results From Independent Study Building On Growing Body Of Evidence For Clinical Application Of The Surfacer System

  10/27/2018

  Data presented at the 2018 American Society of Nephrology (ASN) Annual Meeting

• Bluegrass Vascular Announces Enrollment Completion Of International Post-Market SAVE Registry With Early Positive Results

  10/15/2018

  IDE study, SAVE-US, expands patient enrollment and further demonstrates positive trends

• Bluegrass Vascular Announces Enrollment of First Patients in U.S. Pivotal Trial

  1/18/2018

  Bluegrass Vascular Technologies today announced the enrollment of its first patients in the SAVE-US pivotal trial.

• First Patients Enrolled In Bluegrass Vascular Post-Market SAVE Study

  4/24/2017

• Bluegrass Vascular Announces Strategic Relationship With Merit Medical

  3/6/2017

• Bluegrass Vascular Wins CE Mark Approval and Announces Successful Commercial Use of The Surfacer Inside-Out Access Catheter System

  8/30/2016

• Bluegrass Vascular Technologies, Inc. Announces First Clinical Use Of The Surfacer Inside-Out Access Catheter System In Europe

  3/29/2016

• Bluegrass Vascular Technologies, Inc. Names Dr. Gabriele Niederauer President And CEO

  9/2/2014